Ikoma, Japan

Akihiro Kasai


Average Co-Inventor Count = 3.2

ph-index = 3

Forward Citations = 30(Granted Patents)


Location History:

  • Nara, JP (2004)
  • Ikoma, JP (2005 - 2006)

Company Filing History:


Years Active: 2004-2006

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Akihiro Kasai: Innovator in Pharmaceutical Composition and Liposome Preparations

Introduction

Akihiro Kasai is a notable inventor based in Ikoma, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of stabilized pharmaceutical compositions and liposome preparations. With a total of 4 patents to his name, his work has the potential to impact medical treatments significantly.

Latest Patents

Among his latest patents, one includes a stabilized pharmaceutical composition in lyophilized form. This composition comprises a cyclic polypeptide compound represented by a specific general formula, which includes various chemical components that enhance its stability. Another notable patent is for liposome preparations that contain a pipecolic acid derivative. This preparation is designed for rapid action in emergency situations, such as cerebral infarction, and is characterized by the absence of cholesterol as a stabilizer.

Career Highlights

Throughout his career, Akihiro Kasai has worked with prominent companies in the pharmaceutical industry. He has been associated with Fujisawa Pharmaceutical Company, Ltd. and Astellas Pharma GmbH. His experience in these organizations has contributed to his expertise in pharmaceutical innovations.

Collaborations

Kasai has collaborated with esteemed colleagues, including Kazumi Ohtomo and Seiji Sawai. These partnerships have likely enriched his research and development efforts, leading to the successful patents he holds today.

Conclusion

Akihiro Kasai's contributions to pharmaceutical innovations, particularly in stabilized compositions and liposome preparations, highlight his role as a significant inventor in the field. His work continues to pave the way for advancements in medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…